Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 207

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 207
---
 lead to, an 
 Acquisition Proposal;                                                                                                                                                                                                                           |

| • |     | approve, endorse or recommend an Acquisition Proposal, or publicly propose to accept, approve endorse or 
 recommend any publicly announced Acquisition Proposal;                                                   |

| • |     | approve, recommend or enter into, or propose to approve, recommend or enter into, any letter of intent,                                                                                                            
 memorandum of understanding, merger agreement, acquisition agreement, or other similar contract (other than an Acceptable Confidentiality Agreement, or such other permitted confidentiality agreement pursuant to 
 no-shop provisions of the Merger Agreement) with respect to an Acquisition Proposal; or                                                                                                                            |

| • |     | propose, resolve, authorize, agree or commit to do any of the foregoing. |

In addition, from the date of the Merger Agreement until the earlier to occur of the Effective Time or the termination of the Merger Agreement, Enfusion will, and will cause its subsidiaries to, and will direct Enfusion’s and its subsidiaries’ representatives to, promptly after the execution and delivery of the Merger Agreement: (1) in any event within 24 hours of the execution and delivery of the Merger Agreement, cease and terminate any existing discussions, communications or negotiations with any third party, theretofore conducted by Enfusion, its subsidiaries or their respective representatives with respect to an Acquisition Proposal and terminate all access of any third party to any physical or electronic data room (or other diligence access) maintained by Enfusion or its representatives and (2) in any event within three business days after the execution and delivery of the Merger Agreement, distribute written demand for the return or destruction of all copies of any confidential information regarding Enfusion or any of its subsidiaries provided to any third party (including prior to the date of the Merger Agreement) in accordance with the terms of the confidentiality agreement with such third party. Notwithstanding these restrictions, if, at any time on or after the date of the Merger Agreement, but prior to obtaining the Stockholder Approval, (1) Enfusion receives a written Acquisition Proposal from a third party, (2) such Acquisition Proposal did not result from a material breach of the no-shop provisionsof the Merger Agreement and (3) the Special Committee determines in good faith, after consultation with an Enfusion Financial Advisor and outside legal counsel, that such Acquisition Proposal constitutes, or would reasonably be expected to lead to, a Superior Proposal and that the failure to take the actions contemplated by the following clauses (x) or (y) would be inconsistent with the